DC Healthcare Holdings (0283) Fair Value & Analysis
Healthcare · MY · Market cap 99.6M MYR
Fair value as of: Jul 12, 2026
From 22 valuation models · updated 29 days ago
Share price +10.0% over the past month.
Below-average quality, and screening another 73% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (0.0500 MYR). The favourable scenario is already priced in.
- Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
37‑month range 0.0950 MYR – 0.5300 MYR · fair‑value band 0.0300 MYR – 0.0500 MYR · the 0.1100 MYR price screens above the 0.0300 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.
Analysis
DC Healthcare Holdings (0283) currently trades at 0.1100 MYR, while our model-based Fair Value estimate is 0.0300 MYR, implying the stock looks roughly 72.7% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, DC Healthcare Holdings generated revenue of 90.5M MYR at a net margin of 1.3%. Revenue grew 19.3% year over year. It earns a return on equity of 2.6%. Net debt stands at 3.1M MYR. Fundamentals as of Jul 12, 2026
Our scenario range runs from 0.0300 MYR (bear case) to 0.0500 MYR (bull case); at 0.1100 MYR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 39% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -73%, 0283 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Multiples (0.0600 MYR) versus Earnings-Based (0.0100 MYR). Highest evidence: Growth DCF (80).
Notify me when 0283 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 51 · Market factors (momentum, volatility) 30
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
DC Healthcare Holdings Berhad, an investment holding company, provides aesthetic medical services specializing in non-invasive and minimally invasive procedures in Malaysia.
Full company description
DC Healthcare Holdings Berhad, an investment holding company, provides aesthetic medical services specializing in non-invasive and minimally invasive procedures in Malaysia. The company offers aesthetic services, including facial and skin treatments, facial sculpting, body contouring, and hair growth and removal; and general medical consultation services comprising annual health check-ups and skin disease treatment, as well as sells skincare products to under the newB brand name through online stores. The company was founded in 2016 and is headquartered in Kuala Puchong, Malaysia. DC Healthcare Holdings Berhad is a subsidiary of DC Healthcare Group Sdn Berhad.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
DC Healthcare Holdings reported revenue of 87.0M MYR in FY2025 versus 25.5M MYR in FY2021, a compound +35.9%/yr. Reported net income was 206K MYR in FY2025, compounding −54.0%/yr from FY2021.
0283 screens 73% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare DC Healthcare Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is DC Healthcare Holdings (0283) overvalued or undervalued?
What is the fair value of 0283?
What is the quality score of 0283?
What is the revenue of DC Healthcare Holdings (0283)?
What is the net profit margin of 0283?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track DC Healthcare Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.